Advanced thin-film technique could deliver long-lasting medication
Nanoscale, biodegradable drug-delivery method could provide a year or more of steady doses.
Model of viral lifecycle could help in finding a cure for hepatitis B
New technique sustains virus in liver cells, allowing study of immune response and drug treatments.
Advancing medicine, layer by layer
Studies by graduate students Stephen Morton and Nisarg Shah show progress toward better cancer treatment and bone replacement.
Faculty highlight: Paula Hammond
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
Expanding the power of RNA interference
RNA carried by new nanoparticles can silence genes in many organs, could be deployed to treat cancer.
Chemotherapy timing is key to success
Nanoparticles that stagger delivery of two drugs knock out aggressive tumors in mice.
Fast way to measure DNA repair
Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.
Tracking oxygen in the body
MRI sensor that enables long-term monitoring of oxygen levels could aid cancer diagnosis and treatment.
Targeting cancer with a triple threat
MIT chemists design nanoparticles that can deliver three cancer drugs at a time.
Making cancer drugs better
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.
How to build a biotech renaissance: MIT in Kendall Square
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.
New view of tumors’ evolution
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Precision attack on cancer
Michael Hemann seeks better ways to deploy chemotherapy drugs and overcome tumor resistance.